Redwood Wealth Management Group, LLC Unicycive Therapeutics, Inc. Transaction History
Redwood Wealth Management Group, LLC
- $133 Billion
- Q2 2024
A detailed history of Redwood Wealth Management Group, LLC transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Redwood Wealth Management Group, LLC holds 3,000 shares of UNCY stock, worth $1,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$1,140% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding UNCY
# of Institutions
25Shares Held
17.4MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.47MShares$1.32 Million0.26% of portfolio
-
Logos Global Management LP San Francisco, CA3.47MShares$1.32 Million0.16% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$1.07 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.63MShares$1 Million0.02% of portfolio
-
Bvf Inc San Francisco, CA2.2MShares$836,0000.03% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $5.72M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...